» Articles » PMID: 19788408

Sensitivity Analysis on a Physiologically-based Pharmacokinetic and Pharmacodynamic Model for Diisopropylfluorophosphate-induced Toxicity in Mice and Rats

Overview
Publisher Informa Healthcare
Specialty Toxicology
Date 2009 Oct 1
PMID 19788408
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

A physiologically-based pharmacokinetic and pharmacodynamic (PBPK/PD) model was recently developed to study the effect of diisopropylfluorophosphate (DFP) on acetylcholinesterase (AChE) activity in mouse and rat. That model takes into account relatively complex interactions involving many parameters, some of which may be uncertain and/or highly variable, especially those characterizing AChE activity after DFP intoxication. The primary objective of this study was to identify parameters that contribute most to the variability of AChE dynamics for model optimization against data. For this purpose, the influence of the variability of the rate constants for synthesis (K(syn)) and degradation (K(deg)) of AChE, and regeneration (K(reg)) and aging (K(age)) of inhibited AChE on the variability of AChE activity in mice and rat venous blood and brain was first calculated by a global sensitivity analysis. Next, the mouse PBPK/PD model was calibrated by optimizing the values of K(syn), K(deg), K(reg) and K(age). Thereafter, scale-up of the DFP-induced AChE activity was performed from mouse to rat. Validation of the rat model was performed by comparing the time course of venous blood and brain AChE activities from a Monte Carlo analysis to those obtained in vivo. Sensitivity analysis on the verified models showed that K(reg) and K(syn) were the most influential factors of AChE activity at shorter and longer durations, respectively, after DFP challenge. Scale-up of the AChE dynamics from mouse to rat was also successful, as evidenced by significant overlapping between the predicted 95(th) percentile confidence intervals and the experimental data.

Citing Articles

Proinflammatory cytokines, oxidative stress, and organ function as biomarkers of soman (GD) chronic neurotoxicity.

Massey N, Vasanthi S, Gimenez-Lirola L, Tyler H, Thippeswamy T Sci Rep. 2025; 15(1):9021.

PMID: 40089647 DOI: 10.1038/s41598-025-94190-z.


Differential Impact of Severity and Duration of , Medical Countermeasures, and a Disease-Modifier, Saracatinib, on Brain Regions in the Rat Diisopropylfluorophosphate Model.

Gage M, Putra M, Gomez-Estrada C, Golden M, Wachter L, Gard M Front Cell Neurosci. 2021; 15:772868.

PMID: 34720886 PMC: 8555467. DOI: 10.3389/fncel.2021.772868.


Current Approaches and Techniques in Physiologically Based Pharmacokinetic (PBPK) Modelling of Nanomaterials.

Utembe W, Clewell H, Sanabria N, Doganis P, Gulumian M Nanomaterials (Basel). 2020; 10(7).

PMID: 32610468 PMC: 7407857. DOI: 10.3390/nano10071267.


A framework for 2-stage global sensitivity analysis of GastroPlus™ compartmental models.

Scherholz M, Forder J, Androulakis I J Pharmacokinet Pharmacodyn. 2018; 45(2):309-327.

PMID: 29423863 DOI: 10.1007/s10928-018-9573-1.


Discovery of New Classes of Compounds that Reactivate Acetylcholinesterase Inhibited by Organophosphates.

Katz F, Pecic S, Tran T, Trakht I, Schneider L, Zhu Z Chembiochem. 2015; 16(15):2205-2215.

PMID: 26350723 PMC: 4664178. DOI: 10.1002/cbic.201500348.